A detailed history of Investment House LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Investment House LLC holds 17,297 shares of GILD stock, worth $1.52 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
17,297
Previous 17,797 2.81%
Holding current value
$1.52 Million
Previous $1.3 Million 8.98%
% of portfolio
0.07%
Previous 0.08%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 22, 2024

SELL
$63.15 - $72.88 $31,575 - $36,440
-500 Reduced 2.81%
17,297 $1.19 Million
Q3 2023

Nov 09, 2023

SELL
$73.94 - $80.67 $22,182 - $24,201
-300 Reduced 1.66%
17,797 $1.33 Million
Q2 2023

Aug 08, 2023

SELL
$76.01 - $86.7 $30,404 - $34,680
-400 Reduced 2.16%
18,097 $1.39 Million
Q3 2022

Oct 31, 2022

SELL
$59.54 - $68.01 $5,954 - $6,801
-100 Reduced 0.54%
18,497 $1.14 Million
Q2 2022

Aug 09, 2022

SELL
$57.72 - $65.01 $8,658 - $9,751
-150 Reduced 0.8%
18,597 $1.15 Million
Q1 2022

Apr 14, 2022

SELL
$57.92 - $72.58 $252,241 - $316,085
-4,355 Reduced 18.85%
18,747 $1.12 Million
Q3 2021

Nov 12, 2021

SELL
$67.69 - $73.03 $554,381 - $598,115
-8,190 Reduced 26.17%
23,102 $1.61 Million
Q2 2021

Jul 20, 2021

BUY
$63.47 - $69.35 $152,328 - $166,440
2,400 Added 8.31%
31,292 $2.15 Million
Q1 2021

May 06, 2021

BUY
$60.0 - $68.46 $12,000 - $13,691
200 Added 0.7%
28,892 $1.87 Million
Q4 2020

Jan 13, 2021

SELL
$56.65 - $64.55 $39,655 - $45,185
-700 Reduced 2.38%
28,692 $1.67 Million
Q3 2020

Nov 06, 2020

SELL
$62.1 - $78.08 $46,575 - $58,560
-750 Reduced 2.49%
29,392 $1.86 Million
Q1 2020

Apr 08, 2020

SELL
$62.63 - $80.22 $70,959 - $90,889
-1,133 Reduced 3.62%
30,142 $2.25 Million
Q4 2019

Feb 05, 2020

SELL
$61.62 - $67.78 $102,165 - $112,379
-1,658 Reduced 5.03%
31,275 $2.03 Million
Q3 2019

Nov 12, 2019

SELL
$62.51 - $69.0 $217,097 - $239,637
-3,473 Reduced 9.54%
32,933 $2.09 Million
Q2 2019

Aug 05, 2019

BUY
$61.87 - $69.38 $190,312 - $213,412
3,076 Added 9.23%
36,406 $2.46 Million
Q1 2019

May 03, 2019

SELL
$62.53 - $70.05 $187,902 - $210,500
-3,005 Reduced 8.27%
33,330 $2.17 Million
Q4 2018

Feb 06, 2019

SELL
$60.54 - $79.0 $943,697 - $1.23 Million
-15,588 Reduced 30.02%
36,335 $2.27 Million
Q3 2018

Oct 09, 2018

SELL
$71.28 - $78.92 $955,508 - $1.06 Million
-13,405 Reduced 20.52%
51,923 $4.01 Million
Q2 2018

Jul 10, 2018

SELL
$64.88 - $75.68 $228,701 - $266,772
-3,525 Reduced 5.12%
65,328 $4.63 Million
Q1 2018

May 08, 2018

SELL
$72.84 - $88.8 $79,177 - $96,525
-1,087 Reduced 1.55%
68,853 $5.19 Million
Q4 2017

Jan 31, 2018

SELL
$71.15 - $83.52 $100,677 - $118,180
-1,415 Reduced 1.98%
69,940 $5.01 Million
Q3 2017

Oct 30, 2017

BUY
$72.11 - $85.47 $5.15 Million - $6.1 Million
71,355
71,355 $5.78 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Investment House LLC Portfolio

Follow Investment House LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Investment House LLC, based on Form 13F filings with the SEC.

News

Stay updated on Investment House LLC with notifications on news.